Broadwood Partners Comments on STAAR Surgical Shareholders' Rejection of the Company's Proposed Sale to Alcon

Core Viewpoint - Broadwood Partners, L.P. and its affiliates, owning 30.2% of STAAR Surgical Company, announced that shareholders decisively rejected the proposed acquisition of STAAR by Alcon Inc. during the Special Meeting of Shareholders [1] Group 1 - Broadwood Partners and affiliates hold a significant stake of 30.2% in STAAR Surgical Company [1] - The Special Meeting of Shareholders was held to discuss the acquisition proposal by Alcon Inc. [1] - Preliminary results indicate a strong rejection from shareholders regarding the acquisition [1]